To assess the effect of Homoeopathic mother tincture Chelidonium majus in cases of Non Alcoholic Fatty Liver Disease with Dyslipidemia (excess cholesterol).

A clinical study to assess the effect of Homoeopathic mother tincture Chelidonium majus in cases of Non Alcoholic Fatty Liver Disease with Dyslipidemia

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/01/039490

Enrollment

Registered

2022-01-17

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K760- Fatty (change of) liver, not elsewhere classified

Interventions

Intervention1: Homoeopathic mother tincture (Chelidonium majus): Homoeopathic mother tincture Chelidonium majus Form - liquid Route of administration - Oral Duration of therapy - 6months Control Inter

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients with grade I, grade II and grade III nonalcoholic fatty liver disease will be considered. 2.Patients with known case of type 2 diabetes mellitus who are on conventional treatments with HbA1c not more than 8%. 3.Patients who have willingly join the study and signed the written informed consent

Exclusion criteria

Exclusion criteria: 1.Patients who have alcoholic fatty liver disease 2.Patient who has been diagnose with Viral hepatitis or auto immune hepatitis 3.Patients who have any other metabolic disease like Hereditary hemochromatosis, Alpha 1 antitrypsin deficiency , Wilson disease, Uncontrolled thyroid disease 4.Patients who are diagnosed with liver disease due to any other etiology 5.Patient with active cardio pulmonary manifestations.

Design outcomes

Primary

Measure	Time frame
To assess effectiveness of homoeopathic remedy Chelidonium majus (Mother tincture) in reversing the grade of non alcoholic fatty liver disease in dyslipidemia patients. Timepoint: 1.Ultra sonography of Abdomen will be done at beginning of study and will be repeated after 6 months till the completion of study. 2.Lipid profile,Liver function test,HbA1c,Fasting Blood Sugar Test (FBS) Post-Prandial Blood Sugar (PPBS) will be done at beginning of study and will be repeated after every 3months. 3.HBsAg and HCV will be done at beginning of study.	—

Measure

Time frame

To assess effectiveness of homoeopathic remedy Chelidonium majus (Mother tincture) in reversing the grade of non alcoholic fatty liver disease in dyslipidemia patients. Timepoint: 1.Ultra sonography of Abdomen will be done at beginning of study and will be repeated after 6 months till the completion of study. 2.Lipid profile,Liver function test,HbA1c,Fasting Blood Sugar Test (FBS) Post-Prandial Blood Sugar (PPBS) will be done at beginning of study and will be repeated after every 3months. 3.HBsAg and HCV will be done at beginning of study.

—

Secondary

Measure	Time frame
To see the improvement in the dyslipidemia by lipid profile. Timepoint: will be done at beginning of study and will be repeated after every 3months.	—

Countries

India

Contacts

Public ContactDr Changlani sagar

B.V.D.U.Homoepathic Medical College and Hospital,Department of Post Graduate and Research Centre

mrinal.nerlekar@bharatividyapeeth.edu9422321397

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026